Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 5 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Join our Mission to Protect Humankind!
Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.
WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:
*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.
*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.
Summary:
The Vice President, Insights & Analytics (I&A) is a newly created role responsible for building Vaxcyte’s commercial insights, analytics, and forecasting capabilities, beginning with the U.S. adult launch of VAX-31. This leader will oversee the existing Market Research and Competitive Intelligence team while establishing new commercial analytics capabilities, bringing these functions together into an integrated organization that informs strategic and operational decision-making across the Commercial organization.
The VP, I&A will translate market research, customer insights, competitive intelligence, claims data, and commercial performance data into actionable insights that inform strategy, resource allocation, forecasting, and execution. As a trusted advisor to commercial and executive leadership, this role will provide a clear, integrated view of market dynamics, customer needs, competitive developments, and business performance to identify risks and opportunities and support confident, data-driven decisions.
This role sits within the Commercial organization and will partner closely with the Commercial Leadership Team, including the Launch Lead and leaders across Marketing, Sales, Market Access, and Digital Enablement, as well as Finance, Medical Affairs, and Scientific Affairs. The role will own the business questions, analytical priorities, interpretation, and communication of insights, while partnering with Digital Enablement, which owns the systems, platforms, and AI-enabled tools that support data access and analytical capabilities at scale.
Essential Functions:
Insights & Analytics Strategy and Organizational Leadership
• Define and execute the I&A strategy, operating model, and phased capability build to support pre-launch, launch, and commercial growth, including organizational design, talent, budget, and external partnerships.
• Build and lead a high-performing team spanning market research, competitive intelligence, forecasting, and commercial analytics, establishing I&A as a trusted center of excellence and source of actionable insights across the organization.
• Establish data acquisition, governance, and utilization priorities in partnership with Digital Enablement to support integrated, reliable, and timely decision-making.
Market Insights, Competitive Intelligence, and Forecasting
• Lead market research and competitive intelligence to deepen understanding of healthcare professionals, patients, payers, and the evolving competitive landscape, transla
Apply on employer site ↗